Sith (@sith_sathorn) 's Twitter Profile
Sith

@sith_sathorn

ID: 1031489433919311872

calendar_today20-08-2018 10:33:40

36 Tweet

9 Takipçi

5 Takip Edilen

Sith (@sith_sathorn) 's Twitter Profile Photo

An open-label, multicenter, phase II study of ceritinib in patients with advanced ALK+ non-lung solid tumors and hematological malignancies (ASCEND-10). ascopubs.org/doi/10.1200/JC… We report the lack of ceritinib activity in recurrent GBM in this phase II basket trial.